Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.8 BRL | -15.65% | -4.76% | +138.75% |
May. 16 | Biomm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 18 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
Business Summary
Number of employees: 130
Sales per Business
BRL in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Insulins
100.0
%
| 105 | 100.0 % | 118 | 100.0 % | +12.62% |
Sales per region
BRL in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Brazil
100.0
%
| 105 | 100.0 % | 118 | 100.0 % | +12.62% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Director of Finance/CFO | - | 19-04-15 | |
Luciano Vilela
CTO | Chief Tech/Sci/R&D Officer | - | 14-02-19 |
Chief Operating Officer | - | - | |
Corporate Officer/Principal | - | - | |
Comptroller/Controller/Auditor | - | - | |
Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 14-01-31 | |
Director/Board Member | 84 | 15-10-12 | |
Director/Board Member | 81 | 13-12-15 | |
Chairman | 80 | 13-12-15 | |
Director/Board Member | - | 15-12-17 | |
Director/Board Member | 85 | 13-12-15 | |
Newton de Souza
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 126,841,481 | 42,974,062 ( 33.88 %) | 0 | 33.88 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+138.75% | 321M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- BIOM3 Stock
- Company Biomm S.A.